  | Hubaux, R., Vandermeers, F., Cosse, J.-P., Crisanti, C., Kapoor, V., Albelda, S. M., Mascaux, C., Delvenne, P., Hubert, P., & Willems, L. (19 October 2015). Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models. ERJ Open Research, 1 (2), 00028. doi:10.1183/23120541.00028-2015  Peer Reviewed verified by ORBi |
 | De Brogniez, A., Bouzar, A.-B., Jacques, J.-R., Cosse, J.-P., Gillet, N., Callebaut, I., Reichert, M., & Willems, L. (11 February 2015). Risk of emergence of a hyperpathogenic bovine leukemia virus by mutation of a single envelope N-linked glycosylation site [Poster presentation]. Cancer Resaerch and Televie: the challenge for the next 10 years, Bruxelles, Belgium. |
 | Hamaïdia, M., Cosse, J.-P., & Willems, L. (10 October 2014). Epigenetic regulation of macrophage polarisation [Paper presentation]. Meeting axis 4 Agriculture Is Life, Gembloux, Belgium. |
 | Hamaïdia, M., Cosse, J.-P., & Willems, L. (19 May 2014). Epigenetic regulation of macrophage polarisation [Paper presentation]. GIGA Cancer Day, Liege, Belgium. |
 | Hamaïdia, M., Cosse, J.-P., & Willems, L. (29 April 2014). Epigenetic regulation of macrophage polarisation [Poster presentation]. Cancer vaccines and immunomodulation, Nantes, France. |
 | Hamaïdia, M., Cosse, J.-P., & Willems, L. (July 2013). Effect of bio-sourced compounds on activation of immune cells in the view of to improve immunotherapy of malignant pleural mesothelioma [Poster presentation]. SFR Journée Codorcet, Beauvais, France. |
  | Sainvitu, P., Nasir, M. N., Draguet, F., Nott, K., Lins, L., Crowet, J.-M., Willems, L., Cosse, J.-P., Jérôme, C., & Deleu, M. (30 May 2013). Novel phenolic glycolipids: antioxidant activity and effect on membrane models [Poster presentation]. Knowledge for Growth, Ghent, Belgium. |
 | Sainvitu, P., Nasir, M. N., Draguet, F., Nott, K., Lins, L., Crowet, J.-M., Willems, L., Cosse, J.-P., Jérôme, C., & Deleu, M. (15 May 2013). Biophysical characterization of the interaction of novel aromatic glycolipid surfactants with membrane models [Poster presentation]. ICBCBBE 2013 : International Conference on Bioinformatics, Computational Biology and Biomedical Engineering, Amsterdam, Netherlands. |
 | Sainvitu, P., Nasir, M. N., Nott, K., Lins, L., Crowet, J.-M., Nicks, F., Laurent, P., Willems, L., Cosse, J.-P., Jérôme, C., & Deleu, M. (May 2013). Biophysical characterization of the interaction of novel aromatic glycolipid surfactants with membrane models. World Academy of Science, Engineering and Technology, 77, 840. Peer Reviewed verified by ORBi |
 | Sainvitu, P., Nasir, M. N., Nott, K., Lins, L., Crowet, J.-M., Willems, L., Cosse, J.-P., Jérôme, C., & Deleu, M. (May 2013). Biophysical characterization of the interaction of novel aromatic glycolipid surfactants with membrane models. World Academy of Science, Engineering and Technology, 77, 840. |
 | Vandermeers, F., Neelature Sriramareddy, S., Chrisostome, C., Hubaux, R., Cosse, J.-P., & Willems, L. (2013). The role of epigenetics in malignant pleural mesothelioma. Lung Cancer, 81, 311-318. doi:10.1016/j.lungcan.2013.05.014 Peer Reviewed verified by ORBi |
 | Sainvitu, P., Nott, K., Nicks, F., Laurent, P., Willems, L., Cosse, J.-P., Crowet, J.-M., Lins, L., Jérôme, C., & Deleu, M. (16 November 2012). Synthesis and physico-chemical characterization of fatty esters [Poster presentation]. Journée scientifique SFM-BBM, Louvain-la-neuve, Belgium. |
Cosse, J.-P. (2010). Effet de l’hypoxie sur la résistance des cellules cancéreuses à l’étoposide : Etude de l’apoptose et de l’autophagie [Doctoral thesis, UNamur - Université de Namur]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/85066 |
 | Cosse, J.-P., Rommelaere, G., Ninane, N., Arnould, T., & Michiels, C. (2010). BNIP3 protects HepG2 cells against etoposide-induced cell death under hypoxia by an autophagy-independent pathway. Biochemical Pharmacology, 80, 1160-1169. doi:10.1016/j.bcp.2010.07.009 Peer Reviewed verified by ORBi |
 | Cosse, J.-P., Ronvaux, M., Ninane, N., Raes, M., & Michiels, C. (October 2009). Hypoxia-Induced Decrease in p53 Protein Level and Increase in c-jun DNA Binding Activity Results in Cancer Cell Resistance to Etoposide. Neoplasia, 11, 976-986. doi:10.1593/neo.09632 Peer Reviewed verified by ORBi |
Cosse, J.-P., Sermeus, A., Flamant, L., Ninane, N., Raes, M., & Michiels, C. (2009). Involvement of autophagic pathway in the hypoxia-induced resistance to etoposide in HepG2 [Poster presentation]. Annual meeting of the Belgian Association for Cancer Research, Bruxelles, Belgium. |
 | Cosse, J.-P., & Michiels, C. (October 2008). Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression. Anti-Cancer Agents in Medicinal Chemistry, 8, 790-797. doi:10.2174/187152008785914798 Peer Reviewed verified by ORBi |
Cosse, J.-P., Ronvaux, M., Ninane, N., Raes, M., & Michiels, C. (2008). Hypoxia promotes resistance to etoposide by regulating p53 stability and c-jun DNA-binding activity [Paper presentation]. Annual meeting of the Belgian Association for Cancer Research, Bruxelles, Belgium. |
 | Sermeus, A., Cosse, J.-P., Crespin, M., Mainfroid, V., de Longueville, F., Ninane, N., Raes, M., Remacle, J., & Michiels, C. (2008). Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activity. Molecular Cancer, 7, 27. doi:10.1186/1476-4598-7-27 Peer Reviewed verified by ORBi |
Cosse, J.-P., Ronvaux, M., Ninane, N., Raes, M., & Michiels, C. (2008). Hypoxia promotes resistance to etoposide by regulating p53 stability and c-jun DNA-binding activity [Poster presentation]. Apoptosis World 2008- From mechanisms to applications, Luxembourg, Luxembourg. |
 | Cosse, J.-P., Sermeus, A., Vannuvel, K., Ninane, N., Raes, M., & Michiels, C. (2007). Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines. Molecular Cancer. doi:10.1186/1476-4598-6-61 Peer Reviewed verified by ORBi |
Cosse, J.-P., Sermeus, A., Vannuvel, K., Ninane, N., Raes, M., & Michiels, C. (2006). Differential effects of hypoxia on étoposide induced apoptosis according to the cancer cell lines [Poster presentation]. 194rd Meeting of the Belgian Society of Biochemistry and Molecular Biology and The International Francqui Chair 2005/2006, Gembloux, Belgium. |
 | Minet, E., Cosse, J.-P., Demazy, C., Raes, M., & Michiels, C. (2006). Accumulation of the pro-apoptotic factor Bak is controlled by antagonist factor Mcl-1 availability. Apoptosis, 11, 1039-1047. doi:10.1007/s10495-006-6650-5 Peer Reviewed verified by ORBi |
 | Piret, J.-P., Cosse, J.-P., Ninane, N., Raes, M., & Michiels, C. (2006). Hypoxia protects HepG2 cells against etoposide-induced apoptosis VIA a HIF-1-independent pathway. Experimental Cell Research, 312, 2908-2920. doi:10.1016/j.yexcr.2006.05.018 Peer Reviewed verified by ORBi |
Cosse, J.-P., Sermeus, A., Vannuvel, K., Ninane, N., Raes, M., & Michiels, C. (2006). Differential effects of hypoxia on étoposide induced apoptosis according to the cancer cell lines [Poster presentation]. Annual meeting of the Belgian Association for Cancer Research, Gand, Belgium. |
 | Piret, J.-P., Minet, E., Cosse, J.-P., Ninane, N., Debacq, C., Raes, M., & Michiels, C. (March 2005). Hypoxia-inducible Factor-1-dependent Overexpression of Myeloid Cell Factor-1 Protects Hypoxic Cells against tert-Butyl Hydroperoxide-induced Apoptosis. Journal of Biological Chemistry, 280, 9336. doi:10.1074/jbc.M411858200 Peer Reviewed verified by ORBi |
Cosse, J.-P. (2004). Étude du rôle du facteur de transcription HIF-1 dans l’effet protecteur de l’hypoxie contre l’apoptose [Master’s dissertation, UNamur - Université de Namur]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/85064 |